Comparison between whole exome sequencing (WES) and single nucleotide polymorphism (SNP)-based tumor mutation burden analysis. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback